Psoriasis - Current and Future Players

  • ID: 2610142
  • Report
  • 86 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • Can-Fite Biopharma
  • Celgene
  • Eli Lilly
  • Johnson & Johnson
  • MORE
Psoriasis - Current and Future Players

Summary

The author has released its pharma report, “Psoriasis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Psoriasis Market. The report identifies and analyses the key companies shaping and driving the global Psoriasis market. The report provides insight into the competitive Psoriasis landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by a team of industry experts.

Scope

- Investigation of current and future market competition for Psoriasis
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Psoriasis sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Psoriasis market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Psoriasis market landscape? Identify, understand and capitalize
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • Can-Fite Biopharma
  • Celgene
  • Eli Lilly
  • Johnson & Johnson
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Catalyst

2.2 Related Reports

2.3 Upcoming Related Reports

3 Market Outlook

3.1 Global Markets

3.1.1 Forecast

3.1.2 Drivers and Barriers - Global Issues

4 Current and Future Players

4.1 Overview

4.2 Trends in Corporate Strategy

4.3 Company Profiles

4.3.1 Johnson & Johnson

4.3.2 AbbVie

4.3.3 Amgen

4.3.4 Novartis

4.3.5 Pfizer

4.3.6 Eli Lilly

4.3.7 Merck

4.3.8 LEO Pharma

4.3.9 Celgene

4.3.10 Can-Fite Biopharma

5 Appendix

5.1 Bibliography

5.2 Abbreviations

5.3 Methodology

5.4 Forecasting Methodology

5.4.1 Diagnosed Psoriasis Patients

5.4.2 Percent Drug-Treated Patients

5.4.3 Drugs Included in Each Therapeutic Class

5.4.4 Launch and Patent Expiry Dates

5.4.5 General Pricing Assumptions

5.4.6 Individual Drug Assumptions

5.4.7 Generic Erosion

5.4.8 Pricing of Pipeline agents

5.5 Physicians and Specialists Included in this Study

5.6 Primary Research - Prescriber Survey

5.7 About the Authors

5.7.1 Author

5.7.2 Reviewer

5.7.3 Epidemiologist

5.7.4 Global Director of Therapy Analysis and Epidemiology

5.7.5 Global Head of Healthcare

5.8

5.9 Disclaimer

1.1 List of Tables

Table 1: Global Sales Forecast ($m) for Psoriasis, 2014-2024

Table 2: Global Psoriasis Market - Drivers and Barriers, 2014-2024

Table 3: Key Companies in the Psoriasis Market, 2014

Table 4: J&J’s Psoriasis Portfolio Assessment, 2015

Table 5: J&J’s Psoriasis Portfolio SWOT Analysis, 2015

Table 6: AbbVie’s Psoriasis Portfolio Assessment, 2015

Table 7: AbbVie’s Psoriasis SWOT Analysis, 2015

Table 8: Amgen’s Psoriasis Portfolio Assessment, 2015

Table 9: Amgen’s Psoriasis SWOT Analysis, 2015

Table 10: Novartis’s Psoriasis Portfolio Assessment, 2015

Table 11: Novartis’ Psoriasis SWOT Analysis, 2015

Table 12: Pfizer’s Psoriasis Portfolio Assessment, 2015

Table 13: Pfizer’s Psoriasis Portfolio SWOT Analysis, 2015

Table 14: Eli Lilly’s Psoriasis Portfolio Assessment, 2015

Table 15: Eli Lilly’s Psoriasis Portfolio SWOT Analysis, 2015

Table 16: Merck’s Psoriasis Portfolio Assessment, 2015

Table 17: Merck’s Psoriasis Portfolio SWOT Analysis, 2015

Table 18: LEO Pharma’s Psoriasis Portfolio Assessment, 2015

Table 19: LEO Pharma’s Psoriasis Portfolio SWOT Analysis, 2015

Table 20: Celgene’s Psoriasis Portfolio Assessment, 2015

Table 21: Celgene’s Psoriasis Portfolio SWOT Analysis, 2015

Table 22: Celgene’s Psoriasis Portfolio Assessment, 2015

Table 23: Celgene’s Psoriasis Portfolio SWOT Analysis, 2015

Table 24: Key Launch Dates

Table 25: Key Patent Expiries

Table 26: Key Launch Dates

Table 27: Physicians Surveyed, by Country

1.2 List of Figures

Figure 1: Global Sales for Psoriasis by Region, 2014-2024

Figure 2: Company Portfolio Gap Analysis in Psoriasis, 2014-2024
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Johnson & Johnson
AbbVie
Amgen
Novartis
Pfizer
Eli Lilly
Merck
LEO Pharma
Celgene
Can-Fite Biopharma
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll